Articles tagged with Muscle Cells
A team of researchers has achieved a significant breakthrough in treating Duchenne muscular dystrophy by successfully transplanting healthy muscle cells into patients, showing promise for increasing the production of the missing protein dystrophin. The new clinical trials aim to further assess the treatment's effectiveness and measure ...
Researchers used RNA interference to silence genes regulating muscle cell formation and osteogenic signals. The study found that turning off these inhibitors increased the cells' bone-forming potential, with 60% of mice developing radiologically detectable bone after implantation.
Researchers discovered that prostaglandin E2 activates the pairing of EP1R with beta2AR receptors, reducing their ability to cause muscle relaxation. This may explain why some asthma treatments fail for individuals with elevated PGE2 levels.
Researchers have found that lactic acid is not a waste product, but rather a link between anaerobic and aerobic metabolism. Efficient use of lactic acid enables athletes to generate more energy from their body's fuel sources, reducing fatigue and improving performance.
Researchers developed engineered bladders using patients' own cells, showing improved functional parameters without bowel tissue complications. The procedure has the potential to treat bladder disease, but additional studies are needed for wider adoption.
A study by University of California - San Francisco researchers found that the prostate drug doxazosin blocks alpha 1-adrenergic receptors in heart muscle cells, increasing risk of heart failure. The study suggests blocking these receptors may be a direct cause of heart failure.
Researchers investigated how homeoproteins interact with DNA to determine their binding specificity. The findings reveal new insights into the mechanisms underlying these interactions.
Satellite and side population cells, a major source of muscle repair cells, arise from somites in the embryo. These cells are better at forming muscle than those not produced by somites, offering new hope for treating Duchenne's muscular dystrophy.
The new alliance brings together researchers from Yale and BIPI to explore the intersection of cardiovascular and immunological diseases. Initial projects focus on cytokine pathways, calcium channels, and therapeutic potential in the cardiovascular system.
Researchers created a modified form of troponin I to improve cardiac function in mice and damaged human heart cells. The protein helps the heart respond to stress by boosting performance during periods of hardship.
Researchers used gene therapy to introduce a healthy copy of the dystrophin gene into mice with muscular dystrophy, repairing the entire muscle cell. The technique, developed by Michele Calos, has potential for long-term fixes for various genetic diseases.
Researchers at Johns Hopkins Medicine have successfully created a biological pacemaker using connective tissue cells from lungs and heart muscle cells, paving the way for an alternative to implanted electronic pacemakers. The biopacemaker uses tiny electroactive 'pacing cells' that can fire on their own and regulate the heart's rhythmi...
A mutation in ankyrin-B gene causes cardiac arrhythmia, leading to sudden death in young people. The disorder disrupts calcium balance in heart muscle cells, making patients vulnerable to arrhythmias.
Researchers developed a gene therapy using adeno-associated virus (AAV-8) to deliver a normal copy of the delta-sarcoglycan gene to skeletal and cardiac muscle cells. The treatment showed remarkable improvements in muscle function, structure, and endurance in hamsters with muscular dystrophy.
The study found that suppression of the FOXO1a gene is necessary for ARMS cells to survive and avoid programmed cell death. The researchers believe that targeting this gene could lead to effective treatment options for children with ARMS tumors.
A recent study published in the Proceedings of the National Academy of Sciences has identified a molecular defect in specialized proteins called ryanodine receptors (RyRs) as a possible cause of heart failure. The RyRs malfunction, leading to calcium imbalances that prevent the heart from contracting effectively and relaxing adequately.
Researchers have successfully used human muscle-derived stem cells to restore leak-point pressure in animal models of stress urinary incontinence. The therapy involves injecting the cells into the periurethral muscle, which differentiates into new muscle fibers to prevent atrophy. Clinical trials are underway in Toronto.
Researchers at the University of Pittsburgh Medical Center have successfully treated animals with muscular dystrophy using a miniature gene and new systemic approach, demonstrating significant improvements in muscle function and longevity. The treatment involves delivering a mini-agrin gene via adeno-associated virus vectors, restoring...
A study published in PLoS Medicine found that insulin resistance, a key factor in type 2 diabetes, develops early in life and is linked to weight gain. The researchers studied children of diabetic parents and found that insulin-resistant individuals have impaired energy production in muscle cells, leading to weight maintenance problems.
Researchers at Max Planck Institute find that adult stem cells fuse with muscle cells to form functional tissue, contradicting the long-held idea of transdifferentiation. This discovery has significant implications for stem cell therapies targeting organ regeneration.
A recent study at the University of Bonn found that bone marrow-derived adult stem cells do not take on tissue-specific functions, meaning they cannot replace defective muscle cells. The researchers discovered that the cells migrate into muscle fibers but are unable to produce functioning dystrophin, a key muscle protein.
Researchers understand the mechanism of smooth muscle cell growth, which allows for contraction and expansion of blood vessels. The discovery opens up new avenues for treating vascular disorders by targeting the Foxo4 protein.
A new chemical sealant, poloxamer 188, has been shown to prevent heart failure in mice with muscular dystrophy by improving the heart's ability to relax and fill with blood. The treatment restored normal elastic properties in individual cardiac myocytes, reducing the risk of cardiac damage and failure.
Researchers have successfully isolated and differentiated human mesenchymal stem cells from embryonic stem cells, offering a promising alternative to traditional methods. These cells can differentiate into multiple cell types, including bone, cartilage, fat, and muscle, with high purity and unlimited availability.
Researchers at the Salk Institute found that opposing chemical signals from neurotransmitters sculpt the developing nervous system by preserving synapses between motor neurons and muscle cells. This process helps eliminate unnecessary sites, allowing for more efficient neural connections.
A new study by the University of Pittsburgh Medical Center has found that muscle-derived stem cell cultures can improve leak point pressure and regenerate deficient urethral muscle, even when contaminated with fibroblasts. The research paves the way for a more efficient and effective treatment for urinary incontinence.
A new study demonstrates that moderate thyroid hormone therapy normalizes cardiac cell shape and reduces stress on the heart's wall by nearly 40%. This change may lead to a novel therapeutic approach for heart failure. Further animal studies are needed before human testing.
Researchers have discovered two new experimental drugs that target peroxisome proliferators-activated delta receptors (PFAARä) in muscle cells, increasing glucose absorption and boosting energy production. The findings offer a potential alternative to insulin therapy for patients with Type 2 diabetes.
The American Physiological Society has awarded young investigators in various fields of physiological research, including respiratory physiology and epithelial renal physiology. These awards recognize outstanding promise in the field and support research that could lead to advances in stem cell therapy and gene treatment.
The UCSD team identified isl1+ cardiac progenitor cells in newborn rats and mice, as well as in human heart tissue, which can spontaneously form heart muscle tissue. The discovery raises the possibility of using these cells to correct a wide spectrum of pediatric cardiac diseases.
Researchers pinpoint MuRF1's role in regulating cardiac cellular molecules involved in abnormal heart enlargement. The protein degrades troponin-1, a critical component of the cardiac contractile machinery, suggesting new therapeutic avenues for treating cardiac hypertrophy.
Researchers describe a process regulated by Hedgehog gene that induces formation of fast twitch muscles from slow twitch cells in zebrafish embryos. The findings provide insights into muscle development and potential models for muscular dystrophy.
Researchers transplanted BM-SP stem cells into mice with cardiomyopathy, but found that only 2 muscle fibers expressed restored sarcoglycan levels. The study suggests alternative approaches should be investigated for regenerative medicine.
Researchers at Columbia University have discovered a new treatment that improves memory in mice with Alzheimer's disease. The phosphodiesterase inhibitor rolipram was found to modify gene expression and make brain synapses more resistant to beta-amyloid accumulation.
A new study found that transplanted stem cells from bone marrow cannot become functional heart muscle cells due to their inability to produce the protein sarcoglycan. The researchers tested bone marrow side population cells in mice with a receptor deficiency, but the results were disappointing.
Researchers found that fasting reduces phospholipid levels in the heart by up to 40% after 12 hours, allowing mitochondria to become more energy-efficient. After feeding resumes, phospholipid levels return to normal, but triglyceride levels remain elevated, hinting at a memory of deprivation.
Researchers suggest that skeletal-muscle satellite cells can differentiate into neural cell lineages, potentially repairing damaged muscle or nerve tissue. These stem cells were shown to organise skeletal-muscle fibres in rats with spinal-cord injury and differentiate into astrocytes and neurons.
A study by Kandarian found that muscle atrophy caused by prolonged disuse requires the involvement of nfêb1 and bcl3 genes. The researchers also discovered that NSAIDs like aspirin may partially moderate atrophy, offering a potential therapeutic approach to prevent muscle loss.
Joslin and Stanford researchers have made a breakthrough discovery about muscle regeneration, identifying the specific cells that can give rise to new muscle fibers. Contrary to previous studies, these cells are located near muscle fibers and not in blood-forming tissues like bone marrow.
Bone marrow derived stem cells can give rise to heart muscle cells through transdifferentiation, a process that has sparked debate and potential applications in heart repair and transplantation. The concept challenges traditional dogma of tissue specific stem cell differentiation in adults.
Scientists at UCSF discovered a new protein, SNF-6, that transports neurotransmitter acetylcholine away from the nerve-muscle synapse, potentially treating muscular dystrophy. The protein plays a critical role in clearing excess acetylcholine during intense muscle activity, preventing muscle degeneration.
Researchers discovered that human stem cells can replenish muscle fibers in mice with Duchene muscular dystrophy, offering a potential treatment. In contrast, elevated cyclic AMP levels halted egg maturation in females, while HIV protease inhibitors impaired osteoclasts leading to bone loss.
Researchers have identified a new source of stem cells that can restore dystrophin expression and improve function in dystrophic skeletal muscle. Circulating AC133+ stem cells from humans showed potential in treating muscular dystrophy.
Researchers found that expressing LARGE protein in cells from patients with distinct gene defects can restore alpha-dystroglycan's ability to bind to the extracellular matrix, leading to improved muscle structure and function. This approach may have clinical benefits for patients with muscular dystrophy.
Researchers at the University of Wisconsin-Madison have developed a groundbreaking gene therapy technique that safely delivers therapeutic DNA to muscle cells. The innovative approach, which uses a non-viral method to inject genes into limb veins, has exciting implications for treating muscle and blood vessel disorders.
An international team has defined a previously undescribed inherited cardiac arrhythmia syndrome caused by mutations in the ankyrin-B gene. The syndrome, distinct from Long QT Syndrome, is characterized by abnormal heartbeats and increased risk of sudden death, particularly among young people.
Scientists have identified a key gene, Pax7, that regulates the transformation of adult stem cells into muscle cells in injured tissue. The study showed that introducing Pax7 to these stem cells can enable them to differentiate into functional muscle cells and aid in tissue repair.
Researchers developed two treatments to minimize nerve damage and facilitate nerve recovery, preserving ability to have an erection after radical prostatectomy. Muscle-derived cells and glial cell-derived neurotrophic factors improved erectile function in animal models with cavernous nerve injury.
Researchers found that HDAC inhibitors promote adult muscle growth and regeneration by stimulating follistatin levels in skeletal muscle tissues. Follistatin is proposed as a potential drug target to regenerate healthy new muscle tissues in animal models of muscular dystrophies.
A randomized trial of adult stem cell injections in heart failure patients showed significant improvement in cardiac function. The study found that patients who received stem cells had improved ejection fractions and increased Connexin 43 protein levels, indicating better communication between cells.
Researchers have demonstrated that adipose-derived cells can engraft and differentiate into cardiac myocytes, offering new hope for treating heart disease. The study's findings are consistent with previous research and are being further explored by MacroPore Biosurgery.
Researchers found that blood-forming stem cells lodge in damaged hearts but retain their blood-forming fate, contradicting earlier findings. The study suggests that these cells may not be able to transform into muscle cells, but could still offer some potential for treating heart attack patients
Researchers at Duke University Medical Center have confirmed that cord blood stem cells can differentiate into heart muscle cells and produce a critical enzyme to halt progressive damage. Additionally, cord blood transplants appear to slow or halt brain damage caused by metabolic diseases such as Sanfilippo Syndrome.
Researchers found that insulin-resistant young offspring of type 2 diabetics have increased muscle cell lipid content and reduced mitochondrial energy production. This study suggests a potential genetic cause of insulin resistance in young people with type 2 diabetes.
Scientists at Scripps Research Institute discover a compound, reversine, that can convert muscle cells into precursor cells, which can be converted to other cell types. This breakthrough has the potential to revolutionize stem cell research and make it more practical for medical applications.
Research by Stanford researcher Thomas Rando and postdoctoral scholar Irina Conboy found that older muscles produce less Delta after injury, leading to slower regeneration. However, artificially activating Delta in older muscles restored regenerative ability comparable to younger muscle, suggesting a potential therapeutic target.
Researchers have identified a key molecular signaling system controlling the development of smooth muscle in embryos, which may lead to new treatments for heart disease, cancer, and neurological disorders. The 'Jelly Belly' gene plays a crucial role in signaling primitive cells to become muscle cells.
Researchers at University of Wisconsin-Madison identify a receptor for botulinum neurotoxin B, allowing for improved medical uses and prevention against biological threats. The discovery enables the development of antidotes and protective agents to neutralize the toxin.
Penn researchers suggest novel genetic causes for cardiac hypertrophy and new therapeutic agents against it. They also demonstrate that anti-HDAC drugs can block the development of hypertrophy in animal models.
Researchers have found that stem cells from blood vessels can regenerate wasting muscle in mice with muscular dystrophy-like symptoms. The study's results provide a possible new approach for treating the disease, which currently has no cure.